Be a Part of Asia’s Most Innovative Regulatory Conference!

Be a Part of Asia’s Most Innovative Regulatory Conference!   OVERVIEW Join health authority representatives and industry professionals from Asian and ICH member countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance.   OBJECTIVES This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.   This conference will provide a forum to: • Facilitate discussion on common issues in the regulatory and technical areas in Asia • Encourage greater convergence of regulatory requirements in Asia • Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry Day One – Research and Development Day Two – Good Regulatory Practices Day Three – 21st century Global Regulatory Challenges   Register Online     Program Overview     View PDF Program committee chairs Arun Mishra Director Global Regulatory Affairs GlaxoSmithKline, UK John C.W. Lim Chief Executive Officer Health Sciences Authority, Singapore  Who Should Attend Are you a Representative of Health Authorities, a Regulatory Affairs professional, or a professional involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia? If so, then this conference is for you. Ministries of Health and Medicines Regulatory Authorities Regulatory Affairs Clinical Research and Development Safety and Pharmacovigilance Clinical Trial and Project Management CMC/Quality (Quality, Manufacturing and Controls)   Register Online     Program Overview     View PDF To know more contact Ellen.Diegel@diahome.org.